colorectal cancer

The AI system can also classify abnormal tissues as malignant or benign.  

It can simultaneously notify and sound an alarm for every polyp detected during colonoscopy. 

A new clinical validation study, published in the Journal of Clinical Oncology CCI, found that Medial EarlySign’s artificial intelligence tool flagged about 8 percent of patients in a large trial group that were later diagnosed with cancer or precancerous lesions.

A trio of presenters at HIMSS 2018 shared data from practical machine learning and AI-focused studies that demonstrate how the technologies could reduce costs and improve patients’ outcomes.